Pregnancy outcome following early exposure to maternal luteinizing-hormone-releasing hormone agonist (buserelin).
A human pregnancy exposed to a luteinizing-hormone-releasing hormone agonist (buserelin) in its early stages is reported. The possible mechanisms leading to conception under this mode of treatment and its consequences are discussed.